申请人:SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD.
公开号:US10253010B2
公开(公告)日:2019-04-09
The present invention involves a compound represented by general formula (I), a derivative thereof and a use thereof:
wherein R1, R2, R3, R4, R5a, R5b, R5c and X are defined as in the description.
本发明涉及通式 (I) 所代表的化合物、其衍生物及其用途:
其中 R1、R2、R3、R4、R5a、R5b、R5c 和 X 的定义如说明书所述。